Organon & Co. (1OGN)
MTA
Real-time Data
07:00 AM
Day's Range
11.8452 wk Range
4.86Overview - 1OGN - Organon & Co.
Key Statistics
Valuation
Enterprise Value
8.98B
P/E (Trailing)
‪17.56‬
PEG Ratio
‪-0.65‬
Price / Sales (TTM)
‪0.50‬
Price / Book
‪3.58‬
EV / EBITDA
‪6.72‬
Profitability
Gross Margin
‪54.36%‬
Profit Margin
‪3.41%‬
Operating Margin
‪20.73%‬
Return on Assets
‪5.66%‬
Return on Equity
‪24.03%‬
Ownership
Shares Outstanding
262.60M
Float
242.98M
Held by Insiders
‪0.46%‬
Held by Institutions
‪84.05%‬
Price stats
Beta
‪1.52‬
50-Day Avg
‪11.80‬
200-Day Avg
‪8.62‬
Dividends
Payout Ratio
‪10.26%‬
Frequency
Quarterly
Market Cap - 1OGN - Organon & Co.
Peers - 1OGN - Organon & Co.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on MTA.
- 1OGNMTAOrganon & Co.1.85BMarket Cap+30.77%52-week change17.67P/E (Trailing)‪3.41%‬Profit Margin
- 1LLYMTAEli Lilly and Company853.56BMarket Cap+43.34%52-week change42.55P/E (Trailing)‪33.52%‬Profit Margin
- 1JNJMTAJohnson & Johnson428.46BMarket Cap+34.67%52-week change31.56P/E (Trailing)‪21.48%‬Profit Margin
- 1ABBVMTAAbbVie Inc.344.57BMarket Cap+21.59%52-week change75.36P/E (Trailing)‪9.80%‬Profit Margin
- 1ROMTARoche Holding AG294.63BMarket Cap+27.57%52-week change24.74P/E (Trailing)‪19.60%‬Profit Margin
- 1MRKXMTAMerck & Co., Inc.240.41BMarket Cap+43.93%52-week change125.16P/E (Trailing)‪4.76%‬Profit Margin
- 1NOVNMTANovartis AG238.75BMarket Cap+22.16%52-week change24.05P/E (Trailing)‪22.50%‬Profit Margin
Profile Summary - 1OGN - Organon & Co.
About
Organon & Co. is a science-based global pharmaceutical company that develops and delivers innovative health solutions through a portfolio of prescription therapies. Its primary focus areas include women’s health, biosimilars, and established brands, addressing key therapeutic needs in reproductive health, dermatology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
